Abstract
Organophosphorus nerve agents such as sarin, cyclosarin or tabun are substances originally developed for military purposes. These compounds are able to inhibit an enzyme acetylcholinesterase (AChE; EC 3.1.1.7) via phosphorylation in its active site. AChE reactivators and anticholinergics are generally used as antidotes in the case of intoxication with these agents. In this work, reactivation potency of twenty-one structurally different AChE reactivators was tested in vitro and subsequently, relationship between their chemical structure and biological activity was described. Cyclosarin as an appropriate member of the nerve agents family was chosen to illustrate these relationships.
Keywords: Acetylcholinesterase, reactivators, structure-activity relationship, cyclosarin, organophosphates
Letters in Organic Chemistry
Title: Structure-Activity Relationship of Acetylcholinesterase Reactivators -Antidotes Against Nerve Agents
Volume: 4 Issue: 3
Author(s): Kamil Kuca, Veronika Racakova, Daniel Jun and Jiri Bajgar
Affiliation:
Keywords: Acetylcholinesterase, reactivators, structure-activity relationship, cyclosarin, organophosphates
Abstract: Organophosphorus nerve agents such as sarin, cyclosarin or tabun are substances originally developed for military purposes. These compounds are able to inhibit an enzyme acetylcholinesterase (AChE; EC 3.1.1.7) via phosphorylation in its active site. AChE reactivators and anticholinergics are generally used as antidotes in the case of intoxication with these agents. In this work, reactivation potency of twenty-one structurally different AChE reactivators was tested in vitro and subsequently, relationship between their chemical structure and biological activity was described. Cyclosarin as an appropriate member of the nerve agents family was chosen to illustrate these relationships.
Export Options
About this article
Cite this article as:
Kuca Kamil, Racakova Veronika, Jun Daniel and Bajgar Jiri, Structure-Activity Relationship of Acetylcholinesterase Reactivators -Antidotes Against Nerve Agents, Letters in Organic Chemistry 2007; 4 (3) . https://dx.doi.org/10.2174/157017807780737282
DOI https://dx.doi.org/10.2174/157017807780737282 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Research/Review: Insights into the Mutation-Induced Dysfunction of Arachidonic Acid Metabolism from Modeling of Human CYP2J2
Current Drug Metabolism Proteases and Protease-Activated Receptors (PARs): Novel Signals for Pain
Current Topics in Medicinal Chemistry Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome
Current Vascular Pharmacology Novel Therapies Based on Cationic Antimicrobial Peptides
Current Pharmaceutical Biotechnology Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance
Current Pharmaceutical Design Stroke Lesion Segmentation and Analysis using Entropy/Otsu’s Function – A Study with Social Group Optimization
Current Bioinformatics Medicated Chewing Gum: Patient Compliance Oral Drug Delivery System
Drug Delivery Letters Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction
Current Diabetes Reviews Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors
Current Pharmaceutical Design Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Neuroinflammation and its Modulation by Flavonoids
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Cardiac Stem Cell Characteristics in Physiological and Pathological Conditions
Current Pharmaceutical Design Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Serum miRNAs Signature Plays an Important Role in Keloid Disease
Current Molecular Medicine Secondary Prevention of Atherothrombotic Cerebrovascular Events
Current Vascular Pharmacology High Serum Alkaline Phosphatase Levels in Relation to Multi-Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates
Current Medicinal Chemistry Patients with Polyvascular Disease: A Very High-risk Group
Current Vascular Pharmacology Role of Oxidative and Nitrosative Stress, Longevity Genes and Poly(ADPribose) Polymerase in Cardiovascular Dysfunction Associated with Aging
Current Vascular Pharmacology